New Survey Shows U.S. Companies Face Major Challenges

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Survey Shows U.S. Companies Face Major Challenges Complying with EU General Data Protection Regulations (GDPR)
  • 78 percent of U.S. respondents find the complexity of modern IT services makes it difficult to know exactly where all customer data, including personally identifiable information (PII), resides.
  • 39 percent of U.S. respondents do not anonymize or leverage other techniques to depersonalize customer data before using it in application testing environments.
  • U.S. respondents report that a majority of their business data resides on mainframes, making careful data management on these platforms critical for achieving GDPR compliance.

DETROIT, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Most U.S. businesses with European customers are not prepared to comply with recently-approved EU General Data Protection Regulations (GDPR), which include “right to be forgotten,” data anonymizing and customer consent mandates. U.S. companies will face fines or lawsuits from EU citizens or organizations if they don’t fully comply by the May 2018 deadline.

An independent survey of large company CIOs, conducted by Vanson Bourne and sponsored by Compuware, also showed 52 percent of U.S. companies possess data on EU citizens, making them subject to the GDPR. Primary concerns for these companies are the ability to know where customer data is at all times, and proper concealment of customer data used in testing . While the GDPR applies to customer data on all platforms, U.S. respondents with EU data noted an average of 68 percent of that data resides on mainframes.

“Businesses in breach of the GDPR after May 2018 will likely face huge fines and tarnished brand reputation, making compliance an executive-level issue,” said Chris O’Malley, CEO of Compuware. “Mainframes hold huge volumes of personal customer data that organizations must give their highest priority in overall compliance effort, including the use of data visualization and test data privacy solutions.”

Other key findings from U.S. respondents include:

  • Only 39 percent claim they would be able to identify and locate every instance of an individual’s personal data in their systems, in the event of an individual requesting removal  
  • 31 percent expressed confidence they’d be able to find most, though not all, instances of personal data  
  • 83 percent use live customer data in test systems when testing applications, because they believe the use of live data ensures reliable testing and accurately represents their production environment  
  • 83 percent provide customer data to outsourcers for testing purposes and 78 percent agree that outsourcing makes it more difficult to pinpoint instances of customer personally identifiable information (PII)
  • 71 percent believe the emergence of mobile technologies is one factor making it more difficult to track customer data as it moves through the enterprise

GDPR regulations are designed to protect EU citizens’ ”right to be forgotten.” Any company with European customer data, regardless of its country of origin, must demonstrate its ability to remove every instance of customers’ PII across all systems or platforms at the customer’s request. The GDPR also demands customer data used in processes like application testing be masked to protect identities, even data shared with outsourcers, developers and testers.

Data visualization tools on mainframe systems can help IT administrators easily see and understand the complex interdependencies between various applications and databases. Organizations with mainframes can use these tools to better understand where customer data travels and resides, in order for it to be deleted in accordance with customer privacy requests. Test data privacy solutions can be used to disguise sensitive customer data throughout the application testing process. With more modern transactional applications (particularly mobile) ultimately connecting through the mainframe—and with DevOps and agile approaches increasing the pace and frequency of software roll-outs—proper protection of this test data becomes crucial.

“There are many important and valid reasons for U.S. companies to re-invest in advancement of their mainframe applications—including its ceaselessly growing importance to the business as the system-of-record for mobile, web, social, and IoT applications,” continued O’Malley. “Looming EU GDPR deadlines, however, make it particularly urgent that mainframe owners take action ASAP to both improve their mainframe data governance capabilities—especially when it comes to tracking and anonymizing test data—while also integrating mainframe data and application management as much as possible with the rest of the enterprise environment.”

For more details, read the full copy of the survey with analysis .

Compuware Corporation Compuware empowers the world’s largest companies to excel in the digital economy by fully leveraging their high-value mainframe investments. We do this by delivering highly innovative solutions that uniquely enable IT professionals with mainstream skills to manage mainframe applications, data, and platform operations. Learn more at compuware.com

Follow us on:

Press Contact Kristina LeBlanc, The Medialink Group, kristinawleblanc@gmail.com , (508) 930-5636 Mary McCarthy, Public Relations Manager, Compuware, mary.mccarthy@compuware.com , (313) 227-7088.

For Sales and Marketing Information Compuware Corporation, One Campus Martius, Detroit MI 48226, 800-521-9353, www.compuware.com .

Copyright © 2016, Compuware Corporation. All rights reserved. The Compuware products and services listed within this release are trademarks or registered trademarks of Compuware Corporation.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infotech's 2026 Report Crowns PSA Software Leaders

Updated Category News Views 20

Spotlight on PSA Trailblazers It's 2026, and Infotech has dropped its latest bombshell—the Professional Services Automation Data Quadrant Report. This ain't just your run-of-the-mill software rankings; it's a peek into tools that could make or break project management for service-oriented businesses. Five top dogs, RocketLane, Wrike, Accelo, SAP Professional Services...

Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights

Updated Category News Views 93

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

Continue Reading
AlphaESS Secures Fifth Tier 1 Status Amid Growth

Updated Category News Views 177

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

Continue Reading
GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Updated Category News Views 135

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 93

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 73

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Magnolia Data Breach: Legal Stakes Loom for Seniors

Updated Category News Views 192

Elderly Residents at Risk After Data Breach Well, here we go again — another day, another data breach debacle. This time, it's Magnolia Management putting senior residents' sensitive information on a silver platter for potential cyber intruders. We're talking names, Social Security numbers, and medical records — the whole shebang. When you're handling such crucial...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 23

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 97

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Boldyn Networks Achieves Major Player Status in Private 5G Market

Updated Category News Views 163

Boldyn Networks Achieves Major Recognition in Private 5G Sector Boldyn Networks, a global leader in private networks and shared communications infrastructure, has made waves in the telecommunications industry with its recent recognition as a Major Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment. This validation reflects...

Continue Reading
LinkSquares Debuts All-Agentic CLM Platform for Legal Teams

Updated Category News Views 16

LinkSquares: A Game Changer for Contract Management In the world of legal and business operations, few things eat away at patience—let alone profits—like the cumbersome dance of contract management. Enter LinkSquares, strutting onto the stage with its new all-agentic CLM platform, promising to turn this often painful process into a streamlined operation that saves...

Continue Reading
Sanctuary Medicinals Triumphs at NECANN Cup with Recognition

Updated Category News Views 216

Sanctuary Medicinals Shines at NECANN Cup Boston 2025 Sanctuary Medicinals proudly celebrates a remarkable achievement at the 6th Annual NECANN Cup Boston. The company earned the impressive title of 4th place in the competitive Solvent Concentrates category. This accolade showcases Sanctuary Medicinals' unwavering commitment to excellence, innovation, and quality within...

Continue Reading
Patients Continue Obesity Treatments as Coverage Shrinks

Updated Category News Views 174

The Growing Challenge of Obesity Drug Coverage For many individuals battling obesity, the struggle is not just about losing weight. It’s also about bearing the financial burden of treatments. With increasing limitations from insurers regarding weight-loss drugs, patients are often forced to alter their lifestyles significantly. Vacations are postponed, dining out is...

Continue Reading
Humacyte, Inc. Investors Urged to Act Before Class Action Deadline

Updated Category News Views 123

Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....

Continue Reading